Blood gene expression profiling of neurologic diseases: A pilot microarray study

Yang Tang, Donald L. Gilbert, Tracy A. Glauser, Andrew D. Hershey, Frank R Sharp

Research output: Contribution to journalArticle

85 Citations (Scopus)

Abstract

Background: Tissue gene expression profiling with arrays measures the transcription of thousands of genes. However, this approach cannot be readily used to guide clinical neurologic practice. Objectives: To determine whether clinical neurologic diseases are associated with unique patterns of up- and down-regulated genes in whole blood and to explore the possibility of using peripheral blood as a surrogate tissue in these diseases. Design: Case-control study. Setting: University-based pediatric and adult neurology clinics. Participants: Patients with neurofibromatosis type 1, epilepsy, or Tourette syndrome diagnosed using traditional clinical criteria; controls without disease; and controls with neurologic disease. Main Outcome Measure: Blood gene expression levels of greater than 12000 genes, measured using U95A arrays. Results: Neurofibromatosis type 1 and childhood epilepsy treated with carbamazepine or valproic acid are associated with distinct patterns of blood gene expression. Patients with valproic acid-responsive vs valproic acid-refractory epilepsy formed distinct subclusters. Tourette syndrome was characterized by several gene expression clusters. In 1 cluster, 6 genes - all associated with immune cell function - were overexpressed. Conclusion: Blood gene expression profiling can provide surrogate markers for neurologic diseases without obvious blood phenotypes.

Original languageEnglish (US)
Pages (from-to)210-215
Number of pages6
JournalArchives of Neurology
Volume62
Issue number2
DOIs
StatePublished - Feb 2005
Externally publishedYes

Fingerprint

Gene Expression Profiling
Nervous System Diseases
Valproic Acid
Tourette Syndrome
Epilepsy
Neurofibromatosis 1
Gene Expression
Genes
Carbamazepine
Neurology
Multigene Family
Nervous System
Profiling
Blood
Case-Control Studies
Biomarkers
Outcome Assessment (Health Care)
Pediatrics
Phenotype
Gene

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Blood gene expression profiling of neurologic diseases : A pilot microarray study. / Tang, Yang; Gilbert, Donald L.; Glauser, Tracy A.; Hershey, Andrew D.; Sharp, Frank R.

In: Archives of Neurology, Vol. 62, No. 2, 02.2005, p. 210-215.

Research output: Contribution to journalArticle

Tang, Yang ; Gilbert, Donald L. ; Glauser, Tracy A. ; Hershey, Andrew D. ; Sharp, Frank R. / Blood gene expression profiling of neurologic diseases : A pilot microarray study. In: Archives of Neurology. 2005 ; Vol. 62, No. 2. pp. 210-215.
@article{ae3967fa5ea0442d8bc3064c50a5269a,
title = "Blood gene expression profiling of neurologic diseases: A pilot microarray study",
abstract = "Background: Tissue gene expression profiling with arrays measures the transcription of thousands of genes. However, this approach cannot be readily used to guide clinical neurologic practice. Objectives: To determine whether clinical neurologic diseases are associated with unique patterns of up- and down-regulated genes in whole blood and to explore the possibility of using peripheral blood as a surrogate tissue in these diseases. Design: Case-control study. Setting: University-based pediatric and adult neurology clinics. Participants: Patients with neurofibromatosis type 1, epilepsy, or Tourette syndrome diagnosed using traditional clinical criteria; controls without disease; and controls with neurologic disease. Main Outcome Measure: Blood gene expression levels of greater than 12000 genes, measured using U95A arrays. Results: Neurofibromatosis type 1 and childhood epilepsy treated with carbamazepine or valproic acid are associated with distinct patterns of blood gene expression. Patients with valproic acid-responsive vs valproic acid-refractory epilepsy formed distinct subclusters. Tourette syndrome was characterized by several gene expression clusters. In 1 cluster, 6 genes - all associated with immune cell function - were overexpressed. Conclusion: Blood gene expression profiling can provide surrogate markers for neurologic diseases without obvious blood phenotypes.",
author = "Yang Tang and Gilbert, {Donald L.} and Glauser, {Tracy A.} and Hershey, {Andrew D.} and Sharp, {Frank R}",
year = "2005",
month = "2",
doi = "10.1001/archneur.62.2.210",
language = "English (US)",
volume = "62",
pages = "210--215",
journal = "Archives of Neurology",
issn = "0003-9942",
publisher = "American Medical Association",
number = "2",

}

TY - JOUR

T1 - Blood gene expression profiling of neurologic diseases

T2 - A pilot microarray study

AU - Tang, Yang

AU - Gilbert, Donald L.

AU - Glauser, Tracy A.

AU - Hershey, Andrew D.

AU - Sharp, Frank R

PY - 2005/2

Y1 - 2005/2

N2 - Background: Tissue gene expression profiling with arrays measures the transcription of thousands of genes. However, this approach cannot be readily used to guide clinical neurologic practice. Objectives: To determine whether clinical neurologic diseases are associated with unique patterns of up- and down-regulated genes in whole blood and to explore the possibility of using peripheral blood as a surrogate tissue in these diseases. Design: Case-control study. Setting: University-based pediatric and adult neurology clinics. Participants: Patients with neurofibromatosis type 1, epilepsy, or Tourette syndrome diagnosed using traditional clinical criteria; controls without disease; and controls with neurologic disease. Main Outcome Measure: Blood gene expression levels of greater than 12000 genes, measured using U95A arrays. Results: Neurofibromatosis type 1 and childhood epilepsy treated with carbamazepine or valproic acid are associated with distinct patterns of blood gene expression. Patients with valproic acid-responsive vs valproic acid-refractory epilepsy formed distinct subclusters. Tourette syndrome was characterized by several gene expression clusters. In 1 cluster, 6 genes - all associated with immune cell function - were overexpressed. Conclusion: Blood gene expression profiling can provide surrogate markers for neurologic diseases without obvious blood phenotypes.

AB - Background: Tissue gene expression profiling with arrays measures the transcription of thousands of genes. However, this approach cannot be readily used to guide clinical neurologic practice. Objectives: To determine whether clinical neurologic diseases are associated with unique patterns of up- and down-regulated genes in whole blood and to explore the possibility of using peripheral blood as a surrogate tissue in these diseases. Design: Case-control study. Setting: University-based pediatric and adult neurology clinics. Participants: Patients with neurofibromatosis type 1, epilepsy, or Tourette syndrome diagnosed using traditional clinical criteria; controls without disease; and controls with neurologic disease. Main Outcome Measure: Blood gene expression levels of greater than 12000 genes, measured using U95A arrays. Results: Neurofibromatosis type 1 and childhood epilepsy treated with carbamazepine or valproic acid are associated with distinct patterns of blood gene expression. Patients with valproic acid-responsive vs valproic acid-refractory epilepsy formed distinct subclusters. Tourette syndrome was characterized by several gene expression clusters. In 1 cluster, 6 genes - all associated with immune cell function - were overexpressed. Conclusion: Blood gene expression profiling can provide surrogate markers for neurologic diseases without obvious blood phenotypes.

UR - http://www.scopus.com/inward/record.url?scp=13444252678&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=13444252678&partnerID=8YFLogxK

U2 - 10.1001/archneur.62.2.210

DO - 10.1001/archneur.62.2.210

M3 - Article

C2 - 15710849

AN - SCOPUS:13444252678

VL - 62

SP - 210

EP - 215

JO - Archives of Neurology

JF - Archives of Neurology

SN - 0003-9942

IS - 2

ER -